Skip to content

Effect of obesity on asthma outcomes in acute exacerbation

Effect of obesity on asthma outcomes in acute exacerbation: a multicentre interventional cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN66285433
Enrollment
2000
Registered
2010-08-12
Start date
2010-07-30
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to moderate asthma in acute exacerbation Respiratory Asthma

Interventions

According to Chinese cut-off criteria of obesity, the subjects with asthma are divided into four groups which are the underweight group with BMI less than 18.5 kg/m2, the normal group with BMI between

Sponsors

West China Hospital at Sichuan University (China)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Mild to moderate asthma in acute exacerbation 2. Male and female patients between 15 and 75 years 3. Within 72 hours of onset of acute asthma 4. Ability to provide written informed consent

Exclusion criteria

Exclusion criteria: 1. Use of systemic steroids or immunosuppressive agents within one month before recruitment, or history of life-threatening asthma requiring treatment with intubation and mechanical ventilation 2. Maintenance therapy with symbicort, or rescue therapy with formoterol or anticholinergic agents 3. Current alcoholism or drug abuse 4. Lung diseases other asthma 5. Severe diseases of cardiovascular, hepatic, renal, central nervous system, haematopoietic system cancer 6. Significant medical illness (other than asthma) that is not stable 7. History of respiratory tract infection within the previous 6 weeks 8. Pregnancy or breast-feeding 9. The inability to understand and complete this study 10. Peptic ulcer or gastrointestinal haemorrhage 11. Intolerance to beta-2-agonists or steroids

Design outcomes

Primary

MeasureTime frame
The number of patients with use of systemic steroids and steroid dose, and the number of patients with hospital admission, which are evaluated at days 4 and 8.

Secondary

MeasureTime frame
1. The number of puffs of beta agonists (salbutamol) recorded in asthma diary by the patient himself every day during 7-day study 2. Lung functions (PEF), which are assessed at hours 0, 2, 4, 6, 8, 10, 12 after recruitment, and in morning and evening every day during 7-day of treatment

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026